Granisetron Hydrochloride
Synonym(s):1-Methyl-N-[(3-endo)-9-methyl-9-azabicyclo[3.3.1]non-3-yl]-1H-indazole-3-carboxamide hydrochloride;Granisetron hydrochloride
- CAS NO.:107007-99-8
- Empirical Formula: C18H25ClN4O
- Molecular Weight: 348.87
- MDL number: MFCD01747034
- EINECS: 634-603-0
- SAFETY DATA SHEET (SDS)
- Update Date: 2024-11-11 14:08:43
What is Granisetron Hydrochloride?
Description
Granisetron hydrochloride is the second selective 5HT-3-antagonist approved for the management of nausea and vomiting induced by cancer chemotherapy.Like ondansetron, granisetron hydrochloride is superior to metoclopramide in both efficacy and side effect profile. The compound appears to be effective both as a prophylactic agent and in blocking vomiting once started.
Chemical properties
White to Off-White Crystalline Sold
Originator
SmithKline Beecham (United Kingdom)
The Uses of Granisetron Hydrochloride
anticoagulant
The Uses of Granisetron Hydrochloride
A specific serotonin (5HT3) receptor antagonist. Used as an antiemetic. Granisetron HCl is a serotonin 5-HT3 receptor antagonist used as an antiemetic to treat nausea and vomiting following chemothera py. Its main effect is to reduce the activity of the vagus nerve. It does not have much effect on vomiting due to motion sickness. This drug does not have any effect on dopamine receptors or muscarini c receptor
The Uses of Granisetron Hydrochloride
These Secondary Standards are qualified as Certified Reference Materials. These are suitable for use in several analytical applications including but not limited to pharma release testing, pharma method development for qualitative and quantitative analyses, food and beverage quality control testing, and other calibration requirements.
What are the applications of Application
Granisetron hydrochloride is a SR-3 antagonist
Manufacturing Process
A solution of 1-(phenylmethyleneamino)isatin (1.354 g, 0.0054 mol) and
endo-3-amino-9-methyl-9-azabicyclo[3.3.1]nonane (0.832 g, 0.0054 mol) in
dry THF (25 ml) under argon was heated to reflux for 5 hours. The solution
was cooled and evaporated and the residual traces of THF were azeotropically
removed with dichloromethane. The residue was triturated with ether to give
the intermediate 2-(benzylidenehydrazino)-α-oxophenyl-(9-methyl-9-
azabicyclo[3.3.1]non-3-yl)carboxamide as an orange powder (1.583 g, 73%).
Sodium hydride (50 mg, 60% dispersion in oil) was added to a solution of the
2-(benzylidenehydrazino)-α-oxophenyl-(9-methyl-9-azabicyclo[3.3.1]non-3-yl)
carboxamide in dry THF (2.3 ml) under argon at -50°C. The resultant solution
was warmed to 0°C over 20 min then cooled to -30°C and treated with methyl
iodide (0.020 ml). The solution was allowed to warm to room temperature and
stirred for 24 hours then filtered. The filtrate was evaporated to dryness, and
triturated with chloroform to give the 2-(N-methylbenzylidenehydrazo)-α-
oxophenyl-(9-methyl-9-azabicyclo[3.3.1]non-3-yl)carboxamide as a light
coloured powder (50 mg, 38%). Further trituration of the mother liquor gave
a further crop, (37 mg, 28%, after recrystallisation from chloroform).
A solution of 2-(N-methylbenzylidenehydrazo)-α-oxophenyl-(9-methyl-9-
azabicyclo[3.3.1]non-3-yl)carboxamide (37 mg) in methanol (1 ml) was
treated with 2 N hydrochloric acid (0.1 ml) and left at room temperature for
several hours. Evaporation of the solvent gave the crude product as a brown
oil (36 mg). HPLC and MS analysis confirmed the structure and indicated a
quantitative yield of endo-N-(9-methyl-9-azabicyclo[3.3.1]non-3-yl)-1-
methylindazole-3-carboxamide (Ganisetron).
In practice it is usually used as hydrochloride.
brand name
Kytril (Roche).
Therapeutic Function
Serotonin antagonist
General Description
Pharmaceutical secondary standards for application in quality control, provide pharma laboratories and manufacturers with a convenient and cost-effective alternative to the preparation of in-house working standards.
Biological Activity
5-HT 3 receptor antagonist that possesses potent antiemetic activity.
Biochem/physiol Actions
Granisetron hydrochloride is a serotonin 5-HT3 receptor antagonist and antiemetic.
Pharmacology
Granisetron Hydrochloride is a highly selective 5-HT3 receptor antagonist with good preventive and therapeutic effects on nausea and vomiting caused by radiotherapy, chemotherapy and surgery. Factors such as radiotherapy, chemotherapy and surgery can cause enterochromaffin cells to release 5-HT, and 5-HT can activate 5-HT3 receptors in the central or vagus nerve and cause gag reflex. The mechanism of this product to control nausea and vomiting is to inhibit the occurrence of nausea and vomiting by antagonizing the 5-HT3 receptors in the central chemoreceptor area and peripheral vagus nerve endings.
Pharmacokinetics
After intravenous injection of 20 or 40 μg/kg of this product in healthy subjects, the average peak plasma concentration was 13.7 and 42.8 μg/L, and the plasma elimination half-life was about 3.1-5.9 hours. Granisetron hydrochloride is widely distributed in the body, the serum protein binding rate is about 65%, and most of it is rapidly metabolized. The main metabolic pathway is N-dealkylation and aromatic epoxidation and then conjugated. It is excreted in feces and urine.
Veterinary Drugs and Treatments
Granisetron is an alternative to other 5-HT3 receptor antagonists (e.g., ondansetron or dolasetron) for the treatment of severe vomiting or prophylaxis before administering antineoplastic drugs such as cisplatin that can cause severe vomiting.
storage
Desiccate at +4°C
Properties of Granisetron Hydrochloride
Melting point: | 290-292°C |
storage temp. | Room temp |
solubility | H2O: >10mg/mL |
form | solid |
color | white to off-white |
Merck | 14,4536 |
CAS DataBase Reference | 107007-99-8(CAS DataBase Reference) |
Safety information for Granisetron Hydrochloride
Signal word | Warning |
Pictogram(s) |
Exclamation Mark Irritant GHS07 |
GHS Hazard Statements |
H302:Acute toxicity,oral |
Computed Descriptors for Granisetron Hydrochloride
Abamectin manufacturer
Nivika Chemo Pharma Pvt Ltd
Vepan Pharmatech Pvt Ltd
Orchid Pharma Ltd. (Formerly Known as Orchid Chemicals and Pharmaceuticals Ltd.)
NATCO Pharma Limited
Raising Sun Pharma
Ralington Pharma
New Products
4-AMINO-TETRAHYDRO-PYRAN-4-CARBOXYLIC ACID HCL 4-(Dimethylamino)tetrahydro-2H-pyran-4-carbonitrile 4-Aminotetrahydropyran-4-carbonitrile Hydrochloride (R)-3-Aminobutanenitrile Hydrochloride 3-((Dimethylamino)methyl)-5-methylhexan-2-one oxalate 1,4-Dioxa-8-azaspiro[4.5]decane 5-Bromo-2-nitropyridine Nimesulide BP Aceclofenac IP/BP/EP Mefenamic Acid IP/BP/EP/USP Diclofenac Sodium IP/BP/EP/USP Ornidazole IP Diclofenac Potassium THOMAIND PAPER PH 2.0 TO 4.5 1 BOX BUFFER CAPSULE PH 9.2 - 10 CAP SODIUM CHLORIDE 0.1N CVS ALLOXAN MONOHYDRATE 98% PLATINUM 0.5% ON 3 MM ALUMINA PELLETS (TYPE 73) LITHIUM AAS SOLUTION 2-Bromo-1-(bromomethyl)-3-chloro-5-nitrobenzene 2-Bromo-3-nitroaniline N-(3-Hydroxypropyl)-N-methylacetamide 3-Bromo-6-chloropyridazine 4-ethyl-3-nitrobenzoic acidRelated products of tetrahydrofuran
You may like
-
Granisetron hydrochloride 99%View Details
-
107007-99-8 98%View Details
107007-99-8 -
Granisetron hydrochloride 98%View Details
107007-99-8 -
Granisetron hydrochloride 107007-99-8 99%View Details
107007-99-8 -
Granisetron hydrochloride 107007-99-8 98%View Details
107007-99-8 -
107007-99-8 Granisetron hydrochloride 98%View Details
107007-99-8 -
Granisetron Hydrochloride CAS 107007-99-8View Details
107007-99-8 -
Granisetron hydrochloride CAS 107007-99-8View Details
107007-99-8